Longboard Pharmaceuticals Inc (LBPH) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Longboard Pharmaceuticals Inc   (NASDAQ: LBPH)


Longboard Pharmaceuticals Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Longboard Pharmaceuticals Inc's ROI in the third quarter of 2024?
Longboard Pharmaceuticals Inc recorded a cumulative net loss of $-76 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -33.03%.

Within the Healthcare sector 433 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 3472 to 3771.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM 279.24 % 165.89 % 61.04 % -28.1 % -30.84 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 275 295 314 41 52
Return On Investment (TTM) -33.03 % -36.93 % -49.87 % -97.53 % -83.25 %
LBPH's Overall Ranking # 3771 # 3472 # 0 # 0 # 4205
Seq. Investment Change TTM 31.82 % 50.88 % 108.23 % -8.43 % -7.58 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -76 -65 -58 -54 -51

LBPH Company Profile >> Back to LBPH Roi Comparisons >> See Annual LBPH Return On Investment



Return On Investment LBPH's Ranking
Within: No.
Industry # 173
Sector # 434
Overall # 3771

Return On Investment Statistics
High Average Low
-19.06 %
-50.21 %
-97.53 %
(Mar 31 2021)   (Dec 31 2023)



  News about Longboard Pharmaceuticals Inc Return on Investment ROI

Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phas...

September 9, 2024

Longboard Pharmaceuticals Reports Promising Interim Results for Bexicaserin in Treating Developmental and Epileptic Encephalopathies La Jolla, Calif. Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical entity concentrated on developing innovative therapies for neurological disorders, announced today encouraging interim results from its ongoing 52-week open-label extension of the PACIFIC Study. This research focuses on the efficacy of bexicaserin (LP352) in patients aged 12-65 diagnosed with Developmental and Epileptic Encephalopathies (DEEs).Bexicaserin has emerged as a focal point in Longboard’s portfolio given its potential to mitigate symptoms associated with DEEs, a group of rare and severe epilepsy syndromes characterized by developmental and cognitive impairments. The interim results showcased a positive response, which marks a significant advancement in the ongoing clinical evaluation. Enhancements in seizure control and overall cognitive function have been reported among participants, underscoring the candidate s transformative potential for affected individuals and their families.





Financial Statements
Longboard Pharmaceuticals Inc's III. Quarter Investments $ 275 Millions LBPH's Balance sheet
Longboard Pharmaceuticals Inc's III. Quarter Income $ -25 Millions Quarterly LBPH's Income Statement
LBPH's Income by Division See LBPH's Income by Division


LBPH Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

Total Investments in Millions 41 61 104 0 0
Y / Y Investment Growth -33.43 % -40.61 % - - -
Net Income in Millions -54 -44 -28 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -132.99 % -71.49 % -26.85 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LBPH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LBPH's Competitors
Subscribers only: Roi for Longboard Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for LBPH's Customers

Other Ratios
LBPH's Roa LBPH's Inventory Turnover Ratio LBPH's Growth Rates LBPH's Dividend Statistics
LBPH's Profitability Ratios LBPH's Asset Turnover Ratio LBPH's Dividend Growth
LBPH's Roe LBPH's Valuation Ratios LBPH's Financial Strength Ratios LBPH's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T20:32:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.